RECRUITING

UWCCC Molecular Tumor Board Registry

UWCCC Precision Medicine Molecular Tumor Board Registry

NCT03023202•University of Wisconsin, Madison

Summary

This study seeks to evaluate the clinical utility of the Precision Medicine Molecular Tumor Board, and to track patient outcomes.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Clinically suspected or histologically confirmed solid or hematological malignancy
•Undergoing genetic testing of tumor
•Ability to understand written informed consent document
•Willingness to sign written informed consent document

Exclusion Criteria

•Pediatric patients (age\<18 years) will be excluded due to a lack of expertise on the molecular tumor committee

Locations (1)

University of Wisconsin Carbone Cancer Center

Madison, Wisconsin, United States

Key Dates

Start Date

March 30, 2016

Primary Completion Date

March 1, 2027

Completion Date

March 1, 2027

Last Updated

April 22, 2025

Enrollment

10,000

ESTIMATED participants

Conditions

Hematologic NeoplasmsSolid Neoplasm

Interventions

PMMTB (Precision Medicine Molecular Tumor Board)

OTHER

Contacts

Cancer Connect

CONTACT

8006228922 clinicaltrials@cancer.wisc.edu

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

NCT04704661

Advanced Breast CarcinomaAdvanced Colon Carcinoma+38 more

View study

RECRUITINGPHASE1

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

NCT05039801

Advanced Endometrial CarcinomaAdvanced Head and Neck Squamous Cell Carcinoma+36 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 22, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

RECRUITINGPHASE2